Literature DB >> 6071254

New myopathy with mitochondrial enzyme hyperactivity. Histochemical demonstration.

R F Coleman, A W Nienhuis, W J Brown, T L Munsat, C M Pearson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6071254

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Myopathy with mitochondrial inclusion bodies: histological and metabolic studies.

Authors:  W R Sulaiman; D Doyle; R H Johnson; S Jennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-11       Impact factor: 10.154

2.  [Mitochondrial anomalies with peculiar distribution in a muscular dystrophy with pelvic onset (author's transl)].

Authors:  H Carrier; A Garde; M Tommasi; N Kopp; J F Savet
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

3.  [Sudanophilic (mitochondria) myopathy (author's transl)].

Authors:  F Gullotta; T R Payk; A Solbach
Journal:  Z Neurol       Date:  1974-04-04

4.  The etiology of malignant hyperpyrexia.

Authors:  P Furniss
Journal:  Proc R Soc Med       Date:  1971-02

5.  Mitochondrial functions in five cases of human neuromuscular disorders.

Authors:  A Gimeno; J L Trueba; M Blanco; M Gosalvez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

6.  "Megaconial" mitochondria observed in a case of chronic polymyositis.

Authors:  S M Chou
Journal:  Acta Neuropathol       Date:  1968-12-18       Impact factor: 17.088

7.  Hereditary aspects of malignant hyperthermia.

Authors:  B A Britt; W G Locher; W Kalow
Journal:  Can Anaesth Soc J       Date:  1969-03

8.  The value of electron microscopy in muscle biopsies.

Authors:  P Hudgson
Journal:  Proc R Soc Med       Date:  1970-05

9.  Familial megaconial myopathy: a real nosologic entity. Clinical and histopathologic studies in two siblings.

Authors:  G Pellegrini; M Moggio; A Cheldi; G Scarlato; F M Pistone; P Picco
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.